KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 153 filers reported holding KRYSTAL BIOTECH INC in Q3 2022. The put-call ratio across all filers is 3.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $297,604,380 | -1.0% | 2,565,555 | +0.2% | 4.64% | +13.8% |
| Q2 2023 | $300,639,211 | +114.6% | 2,560,811 | +46.3% | 4.08% | +96.4% |
| Q1 2023 | $140,105,000 | +25.4% | 1,750,000 | +24.1% | 2.08% | +24.4% |
| Q4 2022 | $111,700,200 | +25.7% | 1,410,000 | +10.6% | 1.67% | +1.6% |
| Q3 2022 | $88,868,000 | +25.9% | 1,275,000 | +18.6% | 1.64% | +17.7% |
| Q2 2022 | $70,585,000 | +5.6% | 1,075,000 | +7.0% | 1.40% | +14.3% |
| Q1 2022 | $66,873,000 | +101.3% | 1,005,000 | +111.6% | 1.22% | +116.1% |
| Q4 2021 | $33,226,000 | – | 475,000 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
| Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
| S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
| Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
| Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
| Artal Group S.A. | 412,082 | $32,991 | 1.96% |
| First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
| Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
| Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |